| 2000 - Iowa City, IA |
|
|
The First National Clinical Conference on Cannabis Therapeutics "Science - Based Clinical Applications" Iowa City, Iowa - April, 2000
Statement of Purpose (from Conference Brouchure) Due to marijuana prohibition, healthcare professionals have had no formal means of education about the therapeutic use of cannabis, despite its illegal use by tens of thousands of patients throughout the country. This conference marks the beginning of the re-education for clinicians about the efficacy of cannabis in medical practice. This conference comes after the completion of the Institute of Medicine's (IOM) 18-month study on the medical efficacy of marijuana. The conference is especially designed for physicians, nurses, and other healthcare professionals who care for patients with cancer, HIV/AIDS, glaucoma, chronic pain, spasticity, seizure disorders, orsubstance abuse. Healthcare providers who work in family practice, oncology, HIV/AIDS, pain management, physical medicine rehabilitation, substance abuse treatment, or public health will benefit from this information. The conference will also be of interest to attorneys and health policy advocates as well as patients. Conference Agenda and Faculty Friday, April 7 Overview of the conference: Al Byrne, Lcdr., USN (ret): Co-founder, Patients Out of Time Welcome: Melanie Dreher, RN, PhD, FAAN: Dean, The University of Iowa College of Nursing Opening Address: Janet E. Joy, PhD: Study Director, Institute of Medicine, Marijuana & Medicine: Assessing The Science Base History of Medical Use of Marijuana: Michael Aldrich, PhD: Institute for Community Health Outreach, San Francisco, CA Kevin Zeese, Esq: President, Common Sense for Drug Policy Lawrence Hirsch, Esq: Lead Attorney, Cannabis Patients Class Action Case Meta-Analysis of State Clinical Cancer Studies, Cannabis Efficacy: Richard Musty, PhD - University of Vermont Clinical Review, 3000 Cases: Tod Mikuriya, MD - Practicing Psychiatrist, Berkeley, CA Conducting Cannabis Research in the United Kingdom: Dr. David Hadorn - GW Pharmaceuticals Case Presentations of Legal Marijuana Patients: Glaucoma: Robert Randall, Elvy Musikka, with Paul Palmberg, MD - Bascom Palmer Eye Institute, Miami, Florida Multiple Sclerosis: Barbara Douglass, with Denis Petro, MD - Neurologist, Washington, DC Chronic Pain: George McMahon, Irvin Rosenfeld, with Juan Sanchez-Ramos, MD - University of South Florida The Voices and Experiences of Families and Care Providers: Mae Nutt: Director, Patients Out of Time Scott Imler: President, Los Angeles Cannabis Resource Center Margaret McMahon: Patients Out of Time Saturday, April 8 Cannabis and Human Cannabinoids: Their Potentials as Medicines: David W. Pate, PhD, MSc - HortaPharm BV, The Netherlands Herbal versus Pharmaceutical Cannabis Preparations:John McPartland, DO, MS - Physician, Middlebury, VT Potential Health Risks of Therapeutic Cannabis: Cognitive Effects: Robert Block, MS, PhD - The University of Iowa College of Medicine Physiological Effects: Denis Petro, MD - Practicing Neurologist, Washington, DC Pulmonary Effects: Donald Tashkin, MD - UCLA Use During Pregnancy: Melanie Dreher, RN, PhD, FAAN - The University of Iowa College of Nursing Psychosocial Study of AIDS Patients Using Cannabis: Kathleen Boyle, PhD - UCLA Guidelines for Dosage and Administration of Cannabis: Mary Lynn Mathre, RN, MSN, CARN - University of Virginia Current Marijuana Research and Research Questions: Ethan Russo, MD - University of Montana OPEN FORUM FOR QUESTIONS OF ALL TOPICS DISCUSSED * * * * * * * |